Pravesh brings with him over 29 years of experience in leading complex manufacturing operations and driving operational excellence
The approval introduces a needle-free alternative to injectable GLP-1 therapies
India’s pharmaceutical sector stands at a pivotal inflection point
The state-of-the-art laboratory opens at the Corewell Health Southfield Center in early 2027
Within India, Dabur expects its Home & Personal Care business to deliver double-digit growth,
The company previously completed a $150 million venture investment, acquisition, and recapitalization
Valneva said regaining full rights to the vaccine will allow the company to “assume direct control over its supply chain and commercialization for endemic high-risk countries
Abbott’s latest innovation promises to shift diabetes management from reactive to proactive
The decision positions Yartemlea as the first and only approved inhibitor of the lectin pathway of complement
India’s traditional medicine systems have also earned formal recognition in key bilateral trade agreements
Subscribe To Our Newsletter & Stay Updated
